Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability
Thomas J Dennison,1 Julian C Smith,2 Raj K Badhan,1 Afzal R Mohammed1 1Aston School of Pharmacy, Aston University, Birmingham, 2Viridian Pharma Ltd, Newport, UK Abstract: Cardiovascular disease (CVD) is the leading cause of death among men and women worldwide. In CVD, hypertension and dyslipidemia c...
Saved in:
Main Authors: | Dennison TJ (Author), Smith JC (Author), Badhan RK (Author), Mohammed AR (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization
by: Hesham M. Tawfeek, et al.
Published: (2020) -
Formulation and evaluation of orally disintegrating clopidogrel tablets
by: Gamal Mohamed Mahrous, et al. -
Formulation and evaluation of fast disintegrating tablet of glimepiride
by: Arooj Khalid, et al.
Published: (2018) -
Formulation and development of paediatric orally disintegrating carbamazepine tablets
by: R Canadell-Heredia, et al.
Published: (2022) -
Formulation and in vitro Evaluations of Paracetamol Orally Disintegrating Tablets
by: Azmiera Azimuddin, et al.
Published: (2023)